Published Date: 26 Apr 2023
One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.
Read Full News1.
Kate Middleton Reaches Cancer Treatment Milestone
2.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
3.
Could CT scans be fueling a future rise in cancer cases, as a new study suggests?
4.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
5.
FDA Expands Durvalumab Label to Operable Lung Cancer
1.
A Closer Look at the Effects of Sickle Cell on Eyesight
2.
Modern Techniques in Hematology Across Clinical Settings
3.
Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology
4.
Advanced Pathways in Oncology for Better Care
5.
An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation